Condition: Lichen Planopilaris · Sponsor: Priovant Therapeutics, Inc.
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
This description comes directly from the study's public registry record.
Clinical Trial Administrator · (212) 634-9743 · clinicaltrials@priovant.com
Always discuss trial participation with your own doctor first.
| Clinical Trial Site | Birmingham, Alabama, United States | Recruiting |
| Clinical Trial Site | Phoenix, Arizona, United States | Recruiting |
| Clinical Trial Site | Scottsdale, Arizona, United States | Recruiting |
| Clinical Trial Site | Irvine, California, United States | Recruiting |
| Clinical Trial Site | Oakland, California, United States | Recruiting |
| Clinical Trial Site | Sacramento, California, United States | Recruiting |
| Clinical Trial Site | San Francisco, California, United States | Recruiting |
| Clinical Trial Site | Denver, Colorado, United States | Recruiting |
| Clinical Trial Site | Farmington, Connecticut, United States | Recruiting |
| Clinical Trial Site | New Haven, Connecticut, United States | Recruiting |
| Clinical Trial Site | Miami, Florida, United States | Recruiting |
| Clinical Trial Site | Chicago, Illinois, United States | Recruiting |
+ 49 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07532603